Yantai Zhenghai Biotechnology Co., Ltd. (SZSE: 300653)
Health Care · Biotechnology · CN
CN¥15.94
+1.27% today · -20.5% 1Y
Yantai Zhenghai Biotechnology Co., Ltd. (SZSE: 300653) operates in the Biotechnology industry within the Health Care sector. The company is valued at $422.13M and employs 386 people.
Over the last twelve months the share price has lost 20.5%, trading between 13.37 and 23.36.
Tweenvest scores Yantai Zhenghai Biotechnology Co., Ltd. across four factors: quality 80/100, value 46/100, growth 7/100, dividend 52/100. Its strongest factor is quality.
300653 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $422.13M
- Revenue (TTM)
- $49.47M
- P/E
- 40.80
- EPS
- 0.39
- Dividend yield
- 1.76%
- Beta (5Y)
- 0.06
- 52-week high
- CN¥23.36
- 52-week low
- CN¥13.37
- Avg volume (3M)
- —
- Shares outstanding
- 177.64M
- Employees
- 386
- Next earnings
- —
About Yantai Zhenghai Biotechnology Co., Ltd.
Yantai Zhenghai Biotechnology Co., Ltd., founded in 2003 and based in Yantai, China, specializes in the innovation, manufacturing, and commercialization of regenerative medical materials across China. The company's product offerings include a bone repair material, which is a partially deproteinized substance derived from calf cancellous bone after undergoing a series of processes like decellularization and degreasing. It also provides membranes for oral cavity repair, specifically designed to address shallow soft tissue defects in the mouth. Under the "Heal-All" brand, it supplies biomembranes used in neurosurgical procedures to mend defects of the cerebral dura mater. Additionally, the "Heal-Full" brand encompasses skin repair membranes developed for treating wounds within the dermal layer.
- ISIN
- CNE100002NZ1
- Founded
- 2003
- Listed since
- May 16, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Prothena Corporation plcNasdaqGS: PRTA | $429.18M | $8.61 | +2.99% |
| Egetis Therapeutics AB (publ)OM: EGTX | $425.31M | Skr9.85 | +7.30% |
| GI Innovation, Inc.KOSDAQ: A358570 | $422.52M | ₩8,820.00 | -0.56% |
| Editas Medicine, Inc.NasdaqGS: EDIT | $422.35M | $2.84 | +3.27% |
| Rezolute, Inc.NasdaqCM: RZLT | $420.64M | $4.64 | +15.71% |
| AP Biosciences, Inc.TPEX: 6945 | $416.39M | NT$136.00 | -1.45% |
| AbClon Inc.KOSDAQ: A174900 | $413.34M | ₩27,900.00 | +42.35% |
| Eikon Therapeutics, Inc.NasdaqGS: EIKN | $408.40M | $7.50 | -0.53% |
Figures last refreshed Oct 4, 2026.